Clinical Trial Update: Clinical Trial to Evaluate the Safety and Immunogenicity of Mumps Vaccine [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and immunogenicity of a mumps vaccine completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mumps

Drugs mentioned

• Mumps vaccine

Snippet

Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd. | Conditions: Mumps | Phase 4 | Status: COMPLETED